GKB Ophthalmics has notified stock exchanges of an upcoming Board of Directors meeting scheduled for Wednesday, May 27, 2026, at its Registered Office located at 16-A, Tivim Industrial Estate, Mapusa, Goa. The notice was issued on May 04, 2026, pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The meeting has been convened to consider and approve the Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended March 31, 2026. The key details of the scheduled board meeting are outlined below:

Trading Window Closure

In connection with the board meeting, GKB Ophthalmics has also disclosed the status of the Trading Window for its equity shares. As per the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in the company's equity shares by designated persons had been closed from April 01, 2026. The Trading Window will reopen after the completion of 48 hours from the date of submission of the financial results to the Stock Exchange. This communication has been sent to all Directors and designated employees of the company.

The notice of the board meeting is accessible on the company's official website at www.gkb.net . The announcement was signed by Pooja Dessai née Bicholkar, Company Secretary of GKB Ophthalmics.

GKB Ophthalmics Limited has officially communicated to BSE Limited regarding the non-applicability of a specific SEBI circular to its operations. The company has confirmed that it does not fall under the category of "Large Corporate" as defined by regulatory guidelines.

Regulatory Compliance Notification

In a formal communication dated April 07, 2026, GKB Ophthalmics Limited addressed BSE's Department of Corporate Services to clarify its status regarding SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144. The circular, originally issued on November 26, 2018, by the Securities and Exchange Board of India, contains specific provisions that apply only to companies classified as "Large Corporates."

Company Position and Confirmation

The notification explicitly states that GKB Ophthalmics Limited does not meet the criteria for classification as a "Large Corporate" under the definitions provided in the SEBI circular. This determination means that the specific requirements and provisions outlined in the circular are not applicable to the company's operations or compliance obligations.

Administrative Details

The communication was formally signed by Pooja Dessai née Bicholkar, serving as Company Secretary of GKB Ophthalmics Limited. The document was submitted to BSE Limited for official record-keeping purposes, ensuring proper documentation of the company's regulatory status.

Regulatory Context

SEBI Circular SEBI/HO/DDHS/CIR/P/2018/144 contains specific guidelines and requirements that apply selectively based on company size and classification. By confirming its status as not being a "Large Corporate," GKB Ophthalmics has clarified its position regarding compliance obligations under this particular regulatory framework. The formal notification ensures transparency and proper regulatory alignment for the company's ongoing operations.